ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,992.48
      -1.56%
      US Tech 100
      16,792.80
      -1.57%
      Dow Jones
      37,770.18
      -1.80%
      Brent Oil
      86.695
      -0.60%
      Bitcoin
      63,324.51
      -1.49%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. MannKind Corporation (MNKD)

      7. MannKind Corporation (MNKD) News

      MNKD

      MannKind (MNKD)

      MannKind Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MNKD
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      04/03/20246:00AMGlobeNewswire Inc.MannKind Repays Certain Debt ObligationsNASDAQ:MNKDMannKind Corporation
      03/26/20244:05PMGlobeNewswire Inc.MannKind Announces CFO TransitionNASDAQ:MNKDMannKind Corporation
      03/11/20246:05AMGlobeNewswire Inc.INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin PumpsNASDAQ:MNKDMannKind Corporation
      03/05/20246:05AMGlobeNewswire Inc.MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8NASDAQ:MNKDMannKind Corporation
      03/04/20241:01PMGlobeNewswire Inc.MannKind Corporation Announces Participation at Upcoming ConferencesNASDAQ:MNKDMannKind Corporation
      02/27/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
      02/27/20244:00PMGlobeNewswire Inc.MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development UpdateNASDAQ:MNKDMannKind Corporation
      02/20/20246:00AMGlobeNewswire Inc.MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024NASDAQ:MNKDMannKind Corporation
      02/15/20246:05AMGlobeNewswire Inc.MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®NASDAQ:MNKDMannKind Corporation
      02/05/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      02/05/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      02/05/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      02/05/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      02/05/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      02/05/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      01/02/20246:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
      01/02/20246:05AMGlobeNewswire Inc.MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 MillionNASDAQ:MNKDMannKind Corporation
      12/28/20236:00AMGlobeNewswire Inc.MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
      12/27/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
      12/15/20239:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      12/15/20234:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
      12/14/20237:56PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
      12/14/20234:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
      11/07/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
      11/07/20234:00PMGlobeNewswire Inc.MannKind Corporation Reports 2023 Third Quarter Financial ResultsNASDAQ:MNKDMannKind Corporation
      11/06/20236:15AMGlobeNewswire Inc.MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 DiabetesNASDAQ:MNKDMannKind Corporation
      11/02/20239:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      11/02/20239:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
      11/01/20237:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
       Showing the most relevant articles for your search:NASDAQ:MNKD